Pharmafile Logo

Launch excellence

- PMLiVE

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines today.

With a rapidly changing clinical, economic and regulatory environment, the launch of new products has catapulted the pharmaceutical industry into greater complexity and pressure than ever before. Historically, new asset launches have been a tale of two halves: a hit or miss. Between 2009 and 2017, 40% of worldwide drug launches failed to meet their 2-year sales forecasts, according to McKinsey & Company1. Taking into consideration the evolving environment, there has never been a greater need for new models to navigate the path of an asset to market.

Over the past 15 years, our clients have regularly come to us to help them execute their launch plans. Often the ask is around launch readiness and activation, with a focus on tactical execution. In this article, we discuss the need to get ahead of tactical planning and demonstrate the role of ‘pre-launch asset preparedness’, to ensure we maximise the potential of specialised medicines in this highly complex environment.

You can read the full article online here or download it so you can read it later here.

If you’re planning a launch and looking for some advice, get in touch! We’re hosting free launch-strategy clinics throughout May and June. Contact Cheryl Harrison Doyle or Clare Reynolds for more details.

cheryl.harrisondoyle@wearelucidgroup.com
07818 568882

clare.reynolds@wearelucidgroup.com
07501 989799

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

There’s never a dull moment at Lucid Group

Andrea Hamlin, Angela Tye-Galichet, Emma Herring and Ify Onyeaso were all treated to a fabulous lunch with the Lucid Co-Founders, Dennis O’Brien and Jan Steele in celebration of their 5...

Lucid Group support local charity event

Lucid Group donated 75 Easter chocolate bunnies to a group of local school children organising an Easter Egg Hunt who were raising funds for Médecins Sans Frontières. The egg hunt...

Why health psychology should inform pharma strategy

In the March 2016 edition of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) discusses why pharma should look to health psychology and adopt a behaviour-change strategy to inform...

Lucid Group celebrate 9 years of changing patients’ lives

Lucid Group had fun and games celebrating their nine year anniversary in their London offices last week. Lucid has grown from the two founders working out of a basement to...

It’s time to get with the real world

Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value

A Lucid Induction

Lucid Group kick off 2016 with six new employees

Lucid’s digital responsibility: delivering value by improving patient outcomes

Digital initiatives must address your customer's needs

Lucid Group US: moving on up!

New premises for Lucid Group US

Lucid group celebrate their outstanding year in style at The Shard

A fabulous montage from our end of year meeting at The Shard. Celebrating our achievements the Lucid way.